However, in human MS patient samples, VAMP3 mRNA is downregulated in differentiation-committed oligodendrocytes (COP) across all MS lesion types relative to normal-appearing white matter, suggesting deficient VAMP3 levels in MS pathology (Supplementary Fig. 13d)80. Here, VAMP3 is linked to myeloid sarcoma.